Yesterday it was reported that the CEO & President of Bruker (BRKR), Frank Laukien, exercised options to buy 25,000 BRKR shares at $24.40 a share, for a total transaction value of $610K.
See today’s analyst top recommended stocks >>
Based on Bruker’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $600 million and quarterly net profit of $118 million. In comparison, last year the company earned revenue of $554 million and had a net profit of $78.1 million. The company has a one-year high of $54.49 and a one-year low of $31.18. Currently, Bruker has an average volume of 777.53K.
Three different firms, including Leerink Partners and Needham, currently also have a Buy rating on the stock.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.